WHO WE ARE
BDI, a 501(c)(3) nonprofit organization located in San Diego, California, focuses on addressing the social, emotional, and psychological barriers to living a long and healthy life with diabetes. To better understand and overcome these obstacles, BDI is actively engaged in research examining the psychological aspects of diabetes and evaluating innovative behavioral interventions. In addition, BDI directly offers an array of unique, behaviorally-oriented products and services for: people with type 1 diabetes; people with type 2 diabetes; parents of children and teens with diabetes; spouses and partners of people with diabetes; and interested health care professionals. Products and services include print materials; online courses and modules, face-to-face workshops and seminars, professional training programs, and an online library of resources.
We invite you to explore the resources available to you from BDI. We also welcome your suggestions for additional resources that might be added to our web site. Thank you!
BDI will host our next case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at firstname.lastname@example.org if you are in the greater San Diego area and would like further information about this program and about our future meetings.
April 13, 2022 at 10:00 AM
2022 Virtual Diabetes Event for ICAHN (Illinois Critical Access Hospital Network).
April 26, 2022
BDI’s once-monthly Case Consultation for Diabetes Care Professionals who are not mental health specialists.
April 26, 2022 at 1:00 PM
15th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes), Barcelona, Spain.
April 27-30, 2022
Welcome to BDI’s April 2022 update!
- April 11: Dr. Polonsky is presenting BDI’s one day workshop, “Diabetes Turning Points: Psychosocial Challenges and Behavior Change Solutions in Diabetes”, to healthcare staff at the Sanford USD Medical Center in Sioux Falls, SD.
- April 13: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at email@example.com if you are in the greater San Diego area and would like further information about this program.
- April 26: Dr. Polonsky is presenting on “Addressing Problematic Medication Adherence in Diabetes” at the 2022 Virtual Diabetes Event for ICAHN (Illinois Critical Access Hospital Network).
- April 26: BDI hosts the once-monthly Case Consultation for Diabetes Care Professionals (who are not mental health specialists). This one-hour interactive ZOOM meeting (1 – 2 pm PST) is an opportunity to discuss tough cases together and brainstorm how to best address the behavioral and emotional aspects of diabetes care in the clinical setting. This is limited to only 10 participants each month, so contact us at firstname.lastname@example.org if you would like further information and might want to join us.
- April 27 – 30: It will be a busy time at the 15th International Conference for ATTD (Advanced Technologies and Treatments for Diabetes) in Barcelona. Dr. Polonsky will present on presents on “Using Technology and Behavior Change to Address the ‘Hypo Averse’ patient” (April 28), “Why is My Tech Not Giving Me the Results I Want” (April 29), and” Medical and Psychological Approaches Towards Enhancing the Value of Personal CGM in the Type 2 Population” (April 30, with our good friend from TCOYD, Dr. Steve Edelman).
New professional publications
BDI staff were proud to serve as co-authors on two new peer-reviewed publications this month. The first, “The Role of Retrospective Data Review in the Personal Use of RT-CGM: Perceived Impact on Quality of Life and Health Outcomes”, examines how use of the Dexcom Clarity app affects people with Type 1 diabetes and Type 2 diabetes. The second, “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings,” puts forward a new way of summarizing and understanding CGM data that is likely to be helpful for future researchers, clinicians and people living with diabetes.